Dr. Ankit Mangla, MD
Claim this profileCase Western Reserve University
Studies Skin Cancer
Studies Lymphoma
12 reported clinical trials
19 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
BRAF positive
2Lymphoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Ankit Mangla, MD is currently running
ADI-PEG 20 + Chemotherapy
for Leiomyosarcoma
To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
Recruiting1 award Phase 310 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Ankit Mangla, MD
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Ankit Mangla, MD has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Mirdametinib
- BGB-3245
- CAB-AXL-ADC
Breakdown of trials Ankit Mangla, MD has run
Skin Cancer
Lymphoma
Melanoma
Soft tissue sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ankit Mangla, MD specialize in?
Ankit Mangla, MD focuses on Skin Cancer and Lymphoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ankit Mangla, MD currently recruiting for clinical trials?
Yes, Ankit Mangla, MD is currently recruiting for 7 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Ankit Mangla, MD has studied deeply?
Yes, Ankit Mangla, MD has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Ankit Mangla, MD?
Apply for one of the trials that Ankit Mangla, MD is conducting.
What is the office address of Ankit Mangla, MD?
The office of Ankit Mangla, MD is located at: Case Western Reserve University, Cleveland, Ohio 44106 United States. This is the address for their practice at the Case Western Reserve University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.